Director MPH Program, Head of Department
Health Systems and Populations, Faculty of Medicine and Health Sciences
Janaki Amin’s career has focused on infectious diseases including surveillance for NSW Health, vaccine preventable diseases at the National Centre for Immunisation Research and over fifteen years of research in HIV and Hepatitis C clinical trials and cohort studies at the Kirby Institute. She is currently an investigator in large implementations studies of HIV prevention in NSW (EPIC-NSW) and Hepatitis C treatment in prisons (STOP-C).
Janaki also has expansive experience in developing and delivering teaching and training programs in epidemiology, biostatistics, field research for post-graduate students and health professionals. She has successfully supervised PhD and other research students.
She has been a chief investigator on grants worth over $20 million and has been an author of more than 140 publications. Professor Amin commenced her appointment in the Faculty in 2017.
BSc(Hons) MPH (Hons) PhD
- Clinical trials,
- Cohort studies,
- Data linkage,
- Hepatitis C.
- Hospitalization for Anxiety and Mood Disorders in HIV-Infected and-Uninfected Gay and Bisexual Men
CL Moore, AE Grulich, G Prestage, HF Gidding, F Jin… - JAIDS Journal of Acquired Immune Deficiency …, 2016
- Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, …
ENCORE1 Study Group - The Lancet, 2014
- A prospective study of hepatitis C incidence in Australian prisoners
F Luciani, NA Bretaña, S Teutsch, J Amin, L Topp… - Addiction, 2014
- The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
J Grebely, K Page, R Sacks‐Davis, MS Loeff, TM Rice… - Hepatology, 2014
- Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study
J Amin, MG Law, M Bartlett, JM Kaldor, GJ Dore - The Lancet, 2006
All publications available through google scholar.
Recent Grant Success
- The impact of improving hepatitis c treatment on hepatocellular carcinoma, Cancer Council, 2017
- Risk of hepatitis c reinfection among people with current injecting drug use following successful HCV treatment, NHMRC, 2017
- A randomised trial to compare dolutegravir+darunavir/r versus recommended standard of care antiretroviral regimens in patients with hiv infection who have failed recommended first line therapy, NHMRC, 2016; UNITAID 2017